ABCB1 and colorectal carcinoma: Ma and colleagues demonstrated that CCAL could promote the development of CRC by targeting and activating AP-2α, and the specific mechanism is that CCAL could induce multidrug resistance (MDR) by activating the Wnt/β-catenin signal pathway by inhibiting AP-2α and further promoting MDR1/P-gp expression [4].